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1. Introduction  
In 2011 and 2012, the implementation of the Communal Declaration of January 25th of 2010 
of the Inter-ministerial Conference (B.S. 15.04.2010) continued.  
In this Communal Declaration, the integral and integrated Belgian drug policy is grounded 
and institutionalized. This concept is the core of the Belgian drug policy. The global and 
integrated drug policy is based upon the following pillars: prevention (including early 
detection and early intervention), treatment (including risk reduction for problem drug users) 
and law enforcement for producers and traffickers.  
The development of the Belgian drug policy is executed in close cooperation with the people 
in the work field, i.e. the bottom-up approach, and it is supported by objective data. These 
data are, among others, collected and provided by scientific research.  
Finally, the Belgian drug policy is in line with the European drug policy. 
2. Legal framework  
In comparison to last year, only one new initiative was taken to implement a new. In Februari 
2012, a draft of a third Royal Decree about the implementation of the law on the police about 
road traffic regarding oral fluid and blood analysis is discussed. Please refer to the annual 
report of last year for the most recent information on this topic in Belgium. 
Nevertheless, a survey conducted by The Gallup Organization about the youth attitudes on 
drugs is worth mentioning. This survey reports on the perception of youth about the drug 
policy in Belgium. Most of the Belgian respondents (more than 90%) between the age of 15 
and 24 have the opinion that illicit drugs (ecstasy, heroin and cocaine) should continue to be 
banned. However, the opinion of the respondents is more divided concerning the cannabis 
policy. 47.6 % of them want that cannabis stay illegal, compared to 43.7 % who thinks that 
cannabis have to be regulated. Those respondents were also asked about their perception 
about the appropriate way to handle new substances that imitate the effects of illicit drugs, 
the so-called ‘legal highs’. 18% of the Belgian youth (between the age of 15 and 24) thinks 
that these substances have to be regulated. 43.8% thinks that legal highs have to be banned 
in case they pose a health risk and 32.5 % have the opinion that these substances have to 
be banned in any case (The Gallup Organisation. 2011).  
According to the Belgian respondents of the ‘youth attitudes on drugs’ survey are 1) tough 
measures against drug dealers and traffickers (59.4%); 2) information and prevention 
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campaigns (53.1%); 3) tough measures against drug users (41.3%) and 4) treatment and 
rehabilitation of drug users (26.1%) the most effective strategies to reduce drug related 
problems. This survey shows that the perception of the Belgian population, between the age 
of 15 and 24 years respectively, do not always correspond with the Belgian drug policy (The 
Gallup Organisation. 2011). The current drug policy gives priority to prevention and treatment 
above law enforcement of drug users (Interministeriële Conferentie Drugs 2012a).  
3. National action plan, strategy, evaluation and coordination  
3.1. National action plan and/or strategy 
3.1.1. Federal level 
During the meeting of the General Drugs Policy Cell of the 22nd of June 2011, the results of 
the ‘First international multidisciplinary forum on new drugs’, was discussed. This forum was 
organized by the EMCDDA on the 15th and 16th of May 2011 in Lisbon. The so-called ‘new 
drugs’ or ‘legal highs’ are indeed increasingly becoming an issue in Belgium as well. As is 
the case in other EU member states, this issue necessitates the adaption of the existing 
registration systems and changes in the legislation.  
At the meeting of June 2011, the General Drugs Policy Cell decided to found an ad hoc 
working group ‘legal highs’. The working group is made up of, among others, the Federal 
Agency for the Safety of the Food Chain, the Federal Agency for Medicines and Health 
products, the National Institute for Criminalistics and Criminology, the Scientific Institute of 
Public Health and the Board of Attorney-Generals and representatives of the Ministers of 
Public Health and the Interior. This working group developed a strategic note ‘legal highs’, 
which was approved unanimously by the General Drugs Policy Cell. Following this approval, 
the note was presented and approved by the Inter-ministerial Conference on May 15th of 
2012 as well.  
The approach for ‘legal highs’ is based upon three pillars.  
The first pillar is aimed at removing the judicial and operational obstacles hampering a swift 
and efficient flow of information between each of the partners involved. Up till now, some 
laboratories invoke the secrecy of the investigation to send their information on legal highs 
either too late or not at all to the Early Warning System while the EWS is in particular aimed 
at notifying the authorized services instantly. A change in the law, as proposed in the 
strategic note, should put an end to this situation.  
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A second pillar is aimed at the criminalization of the production of and trafficking in legal 
highs. To this end, two judicial measures are taken. Firstly, the Belgian Drug law will be 
adapted: the production, offer, sale and provision, even without charge, for human 
consumption of substances with a psycho-active effect will be criminalized. Some legal 
substances with a psycho-active effect will stay out of the scope of the changes in the Drug 
law. This is for instance the case for alcoholic beverages, tobacco and some medicines. 
Secondly, some substances with a psycho-active effect will be prohibited based upon the 
basic structure of these substances. Consequently, possible changes in the molecules of 
these substances would still be prohibited. As such, for instance, the synthetic cannabinoids 
will fall under the prohibitions provided in the law.  
Finally, the third pillar of the approach for legal highs will consist of the development of 
appropriate prevention strategies, to optimally inform potential users of legal highs about the 
health risks involved and to discourage their use. To achieve this goal, the Belgian 
authorities will cooperate with the EMCDDA.  
3.1.2. Federate level 
On the 10th of June 2011, a ‘Consensus Conference in the matter of drug-addictions’ was 
held on the initiative of the minister of Health of the Wallonia-Brussels Federation (FWB). It 
was conceived as the extension of two former “round tables” held in the framework of the 
“common policy declaration” and the “concerted plan” in the matter of drug addictions 
between the French-Speaking federate entities. Political responsibles, professionals and 
members of administrations were present at that working session. 
Aiming to prepare that session, two working groups of professionals in the work field had 
been entrusted by the federate entities, respectively, to define the main guidelines of work of 
the different departments of drug-addictions: prevention, treatment, harm reduction 
(“Concept group”), and to realize an inventory of the available services, along with an 
introduction to a training implemented since January 2011 in the University Institute for 
Continuous Training – IUFC - (“Training group”).  
The “Concept group” developed the issue of harm reduction, as that type of intervention 
often remains too poorly recognized to benefit of structural budgets, especially with emerging 
projects, seemingly difficult to endorse for political representatives. The specificity of the 
other sectors (treatment, prevention), the operators and their missions, was also stated in a 
recapitulation document. Lacking time, the “Training group” was not able to realize the 
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inventory as foreseen, and instead presented a complete inventory of the operator’s 
demands.  
On the political side, the cabinet of the minister of Health in FWB conceived a future 
coordination structure which would represent the three French-speaking federate entities: the 
“French-speaking political health and drug-addictions cell”. The latter will pursue three aims: 
1) the organization of priorities of the French-speaking federate entities to be presented at 
federal level; 2) the elaboration of actions to make the offer of services more visible and 
accessible; 3) the organization of increased complementarity and de-compartmentalization of 
resources between the community, regional, municipal and provincial levels. The first task of 
the cell would be to propose a concerted plan in prevention, harm reduction and treatment to 
the field. The strategies that ought to generate that plan are in course of elaboration through 
a broad construction with actors of the field, conducted by the Socio-Epidemiologic 
Observatory Eurotox in a 2-years process (12/2010-12/2012) funded by the FWB 
(“Concerted strategies in drug-addictions”). Moreover, the functioning of the cell would 
include the appointment of a coordinator, funded by all three entities. The latter could lean on 
a work-group composed of specialized actors of the field. 
Furthermore, to pursue the consensus conference, the French-speaking federate entities 
presented a “common political framework”, gathering various global or specific objectives, 
some of them shared by the three levels, some linked to one level only. One can quote the 
global and common objective “diminishing the consumptions”, the specific and shared 
objectives “to delay the age of first consumptions” and “to encourage the complementarity of 
available resources, in an aim of networking”. 
3.2. Implementation and evaluation of national action plan and/or strategy 
3.2.1. Federal level  
In 2009, the General Drugs Policy Cell made up an inventory of the treatment offer for people 
with drug related problems. To this end, several hearings were organized with 
representatives of this sector. Based upon the information gathered during these hearings, 
an overview was developed including the most important bottlenecks with regard to the 
treatment of drug users. The most pressing problems identified were the lack of accurate 
treatment for people in a crisis situation that is linked to their drug use; the financing of 
alternative judicial measures; and a number of projects subsidized by the security and 
prevention plans (of the Federal department of internal affairs) and by the justice department.  
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To supplement the inventory made for drug treatment, the General Drugs Policy Cell 
instructed the Health Drugs Policy Cell to make an inventory of the needs with regard to drug 
prevention and harm reduction. To this end, the secretariat of the Health Drugs Policy Cell 
organized a number of hearings with representatives of both sectors and they analysed the 
relevant policy documents and discussion notes. This resulted in a note that was presented 
to the General Drugs Policy Cell. With regard to prevention, the following needs were 
identified: a lack of people working in the field, a lack of stability and continuity for these field 
workers; the need for better coordination on the policy level; the need for evaluation of the 
effectiveness of prevention strategies; the need for more attention for legal drugs, including 
alcohol; the need for evidence based practices and well trained field workers; the need for 
more attention for problems related to internet use, gaming and gambling; the need for a 
prosecution policy and more strict regulations regarding advertisements; the expansion of 
target groups; and the need for more support for the non-specialised sector. 
With regard to harm reduction, the sector identified the following challenges: the need for an 
expansion of the regulation of needle and syringe exchange; the need to increase the 
attention in drug treatment for harm reduction and needle and syringe exchange; more 
attention for hepatitis B and C; the need for pill testing initiatives; and the need for user 
rooms and distribution machines for syringes.  
On the 25th of January 2012 the Inter-ministerial Conference took note of the bottlenecks with 
regard to drug treatment. During their meeting of May 15th, 2012 the Conference took note of 
the bottlenecks with regard to prevention and harm reduction as well (which were presented 
to the Conference by the General Drugs Policy Cell).  
In response to these notes, the Inter-ministerial Conference instructed an ad hoc working 
group ‘demand reduction’ to develop an action plan with coherent and structural measures 
with regard to prevention, treatment and harm reduction and to present this action plan to the 
Inter-ministerial Conference. This working group is part of the General Drugs Policy Cell and 
is made up of representatives of each of the competent Departments of both the federal and 
federate levels. The ad hoc working group ‘demand reduction’ will present its note in 
September of 2012. 
Next to these initiatives, in 2011, the Belgian Federal Science Policy Office initiated and 
financed a number of scientific studies, to execute the Communal Declaration of January 25th 
of 2011. These studies are:  
Chapter 1: Drug policy: legislation, strategies, and economic analyses 
De Ruyver B., Vander Laenen F, Colman C. & Rwubusisi M.                        7 
1) The production of cannabis in Belgium: evaluation of the nature, the harmful effects and 
implications for priority setting  
2) Compulsive internet use: knowledge base in Belgium, a mixed approach 
3) The drug treatment court in Ghent: a qualitative outcome evaluation 
4) The use of alcohol, illicit drugs, sleep medication and tranquilizers. Prevention and 
treatment by general practitioners and the supervision of health on the job by the medical 
officer. Knowledge, needs and services 
5) Indicators with regard to the offer of illicit drugs.  
3.2.2. Federate levels 
The minister of Health of the French Community (today “Wallonia-Brussels Federation” – 
FWB) has ordered a private consortium, in 2010, to evaluate the Health Promotion 
monitoring system of the FWB. The evaluation report was published in march 2011. It 
pointed mainly the lack of a real planning of Health policy and its implementation, but also of 
a real evaluation of the effects of the policy and the program of Health Promotion. On that 
basis, the minister has presented the orientations of the reformed competences in June of 
2011. Two main measures are emerging: the writing of a new Health Act aiming to give more 
transparency to the legal framework (note: the current decree governing Health Promotion 
was published in 1997), and the creation of an Organization of Public Interest (OIP) which 
will pilot the health policy in the FWB. The main competences to be transferred to the OIP 
are: research, data collection, evaluation, observation, documentation, communication, 
advising, recommendations, programs piloting, screening and vaccinations. These tasks are, 
at the present time, entrusted to various operators (Community Services for Health 
Promotion; Reference centres for Screening; thematic observatories; and some NGOs). The 
latter are supposed to disappear partially or totally, as their missions will be progressively 
integrated to the OIP. Notice that the volume and the framework of employment, according to 
the Minister, would be preserved, since not only the same volume of work will be funded, but 
also the responsible workers will be invited to pursue their tasks in the walls of the OIP. 
Nonetheless, a hearing on that evaluation report have been organized by the parliament of 
the FWB. Indeed, some deputies had been questioned by several NGOs of the field of 
Health Promotion, regrouped in a “Collective of the actors in Health Promotion” on the 
methodology of the evaluation study, on the fact that the study had failed to evaluate the 
needs of the clients (drug users), and on the fact that, according to them, too few of the 
concerned field services had been consulted (and mostly through a written questionnaire) to 
realize the study. The Collective also addressed a “Plea for an ambitious policy” in the matter 
of Health Promotion to the Minister, and published it in a professional review. One of the 
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concerns of the collective was to see that the Promotion of Health becomes increasingly 
defined from a strictly medical point of view, neglecting progressively the “fundamental 
determinants of Health”, as described in the Charter of Ottawa adopted by the World Health 
Organization (WHO). Moreover, the Superior Council for the Promotion of Health (Conseil 
Supérieur de Promotion de la Santé – CSPS) had also published a critical advice on the 
methodology and the context of the evaluation report. 
Two successive auditions took place in the parliament. Questions were addressed, during 
the first audition, to the authors of the report, the president of the CSPS and the General 
Director of Health Administration in FWB. The second audition was the occasion for three 
representative of the field (one NGO, one “Community Service for the Promotion of Health”, 
and the services “Promotion of Health at School”) to meet the political representatives, to 
state the position of the field and to answer questions. It appeared that the field did not reject 
the evaluation report as a whole, and recognized the necessity of a reform, but pleaded for a 
contradictory evaluation and a large debate to guide it, to avoid a “top-down” reform. They 
also pointed that the current paths emerging from the study do not carry unanimous 
adherence.   
Following this process, the minister invited four members of the CSPS to take part to a 
working group, along with a representative of the services “Promotion of Health at School” 
and the concerned members of the cabinet. The workgroup accompanies the writing of the 
draft project of the new Health Code (regular meetings). After the writing, the final version of 
the Code will have to be approved by the CSPS itself. The final text should be submitted to 
the government by the end of 2012, and to the parliament in the first semester of 2013.  
4. Economic analysis  
4.1. Public expenditures 
The information on drug-related public expenditures originates from the research project 
‘Drugs in figures III’ (Vander Laenen 2011), which contains the measurement of the public 
expenditures for the year 2008. The public expenditures of 2008 were compared in the last 
year annual report with the ones of 2004, derived from ‘Drugs in figures II’ (De Ruyver et al. 
2007). For more detailed information about the recent trends of drug-related public 
expenditures and drug services, please refer to Chapter 12 of this annual report.  
The General Drug Policy Cell decided in May 2012 to coordinate the analysis of drug-related 
public expenditure on a yearly basis. This agreement of the different governments and the 
public services in Belgium has the objective to monitor the public expenditures of the drug 
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policy. Each government proposes one responsible to provide the relevant information. 
Besides this, the Secretary of the General Drug Policy Cell has the possibility to appael to 
experts or institutions who are specialised in the drug problem (Interministeriële Conferentie 
Drugs 2012b). The collection of this information is based on the same methodology and 
pillars as defined by ‘Drugs in figures III’ (Vander Laenen 2011). This will assure the 
comparability of the yearly collected information in an database. As such, more reliable data 
have to be available the next years. 
4.2. Budget 
In the framework of the Federal Drug Policy Note of 2001, it is important to know which 
projects are financed by the Federal governement. In order to have a picture of the national 
implementation of the different initiatives, an overview is given about the new (pilot) projects 
financed by the Federal department of Health and the Federal Addiction Fund. This overview 
gives the possibility to indicate the projects which are continued over the years. Most of the 
projects are lasting though a few years.  
The Federal department of Health is financing five pilot projects related as part of the Federal 
Drug Policy Note of 2001. Table 1.1 reports about the financing of the different projects for 
the years 2009, 2010 and 2011. The Federal department of Health was only financing the 
INCANT project in 2009 (217,922 €) and the first four months of 2010 (72,030 €). From May 
2010 on, the Federal Addiction Fund is financing this project. The financing of these projects 
remains globally the same over the years. Only the financing of the TADAM project is 
fluctuating between 205,160 € and 296,742 €. 
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Table 1 1: Budget pilot projects financed by the Federal department  of health for the years 
2009, 2010 and 2011 
Pilot Project Years 
 
2009 2010 2011 
Project ‘International 
Cannabis Need of 
Treatment (INCANT)’ 
217,922 € 72,030 € From May 2010 on, 
these projects are 
financed by the Federal 
Addiction Fund. 
Project ‘coordination 
and care’ 
374,177€ 374,177 € 374,177 € 
Project ‘crisis 
intervention units and 
case-management’ 
3.534,303€ 3,536,890 € 3,536,890 € 
Evaluation of the 
project ‘medically 
controlled supply of 
diacetylmorphine 
(TADAM)’ 
247,062 € 
 
205,159.6 € 
 
296,742.04 € 
 
Project ‘dual diagnosis’ 923,700 € 927,090 € 927,090 € 
Source: Federal Public Health Service 
Previous Belgian National Report reported on 22 projects which were financed in 2008-2009, 
by the Federal Addiction Fund. For this period, the budget amounted to a total of €1,909,363. 
This year, it is the purpose to give an overview about the budget of the Federal Addiction 
Fund of three years, namely 2009 (table 1.2), 2010 (table 1.3) and 2011 (table 1.4). In 2009, 
the Federal Addiction Fund financed 14 projects focussing on the treatment of (illicit) drug 
addictions. For this period the budget amounted to a total of € 1,401,204.  
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Table 1 2: Funded projects by Federal Addiction Fund 2009 
Institution Title of the Project Budget 
Centre ALFA Projet CAMELEON 31,000 € 
Centre Autrement Familles et assuétudes: prise en charge et sensibilisation 77,186 € 
D.U.N.E. Renfort de l'offre de soins du comptoir d'échange de seringues et travail de rue de Bruxelles-Capitale 57,494 € 
DE KIEM 
Ambulante hulp aan drugverslaafden binnen de regelgeving van 
Alternatieve Gerechtelijke Maatregelen, proefzorg en 
drugsbehandelingskamer 
55,000 € 
DE SLEUTEL Versterken van kwantiteit en kwaliteit in de preventie, 
vroegdetectie en hulpverlening 99,640 € 
FREE CLINIC Buddysysteem voor ondersteuning van druggebruikers bij hepatitis C- behandeling 49,466 € 
IDA Campagne Alcool 673,118 € 
IDA 
Ontwikkeling van richtlijnen voor vroegdetectie en kort advies met 
betrekking tot de risico's van alcoholgebruik bij conceptie, 
zwangerschap en borstvoeding 
51,175 € 
INFOR-
DROGUES 
Base de données en ligne bibliodrogues spécilisée dans les 
assuétudes 35,295 € 
Interstices CHU 
St Pierre Projet Liaison Alcools 62,600 € 
KATARSIS Begeleiden en/of aanleren van het ouderschap bij verslaafde personen die in behandeling zijn in Katarsis 32,462.18 € 
KOMPAS Crisishulp aan huis 46,768 € 
VAD 
Ontwikkeling van Good Clinical Practice in de herkenning en 
behandeling van ADHD bij (jong)volwassenen met verslavings 
problemen 
67,500 € 
VAD Kwaliteitsbevordering in de verslavingszorg 62,500 € 
Total  1,401,204 € 
Source: Federal department of Health, Food chain safety and Environment 
In 2010, the Federal Addiction Fund financed 25 projects focussing on the treatment of (illicit) 
drug addictions. For this period the budget amounted to a total of € 1,415,450.50. In 
comparison with 2009 we see an increase in the number of projects wile the budget stays 
quit stable. 
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Table 1 3: Funded projects by Federal Addiction Fund 2010 
Institution Title of the Project Budget 
ASL Verslavingsspreekuur 24,956 € 
CAAT Exploration du besoin de considération du toxicomane 29,000 € 
CAD LIMBURG 
CANNABISHULP: een website met informatie over cannabis 
en online begeleiding bij cannabisproblemen.  50,175 € 
Centre ALFA Projet CAMELEON 30,000 € 
CGG KEMPEN CRA methodiek en een buurtwerking 30,000 € 
CHU BRUGMANN 
Evaluation, prise en charge et soutien à la prise en charge des 
adolescents souffrant d'une assuétude: approche familiale 
multi dimensionnelle 
120,000 € 
D.U.N.E. 
Renfort de l'offre de soins du comptoir d'échange de seringues 
et travail de rue de Bruxelles-Capitale 
72,000 € 
DE KIEM 
Ambulante hulp aan drugverslaafden binnen de regelgeving 
van Alternatieve Gerechtelijke Maatregelen, proefzorg en 
drugsbehandelingskamer 
60,000 € 
DE SLEUTEL 
Versterken van kwantiteit en kwaliteit in de preventie, 
vroegdetectie en hulpverlening 
88,729 € 
DE SPIEGEL 
Handleiding "drugs-drugsgebruik-behandeling" ten behoeve 
van ouders en partners in contact met de drugshulpverlening 
41,190,96 € 
FREE CLINIC 
Buddysysteem voor ondersteuning van druggebruikers bij 
hepatitis C- behandeling 
44,500 € 
IDA 
IDA-web: uitbreding van vlaams en ontwerp van franstalig 
interactive platform voor professionelen en intermediairen 
110,430 € 
Interstices CHU St 
Pierre 
Projet Liaison Alcools 68,800 € 
KATARSIS 
Begeleiden en/of aanleren van het ouderschap bij verslaafde 
personen die in behandeling zijn in Katarsis 27,984.54 € 
KOMPAS Crisishulp aan huis  49,235 € 
LA CAHO asbl 
Implémentation d'un projet de sevrage à domicile de 
personnes alcoolo-dépendantes 
35,500 € 
Le RESSORT Service Plan drogues commune de Tubize 89,500 € 
MSOC OOSTENDE Outreachende, geïntegreerde en pro-actieve begeleiding van 76,640 € 
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drugafhankelijke ouders met jonge kinderen via A(ssertive) 
C(ommunity) T(reatment) 
NAMUR ENTRAIDE 
SIDA 
Développement d'un pôle infirmier et médical dans le comptoir 
l'Echange 
65,450 € 
PopovGGZ 
Optimalisatie van de zorg voor mensen met een verstandelijke 
beperking en een verslavingsprobleem 
71,000 € 
Psychiatrisch 
Centrum OLV 
Psychiatrische thuisbegeleiding voor jongeren (16-35j) met een 
psychotische stoornis in combinatie met middelenmisbruik 
(alcohol, drugs) 
52,600 € 
THAIS 
Soutien à des personnes toxicomanes dans leur fonction 
parentale 
28,000 € 
VAD 
 
Ontwikkeling en implementatie van screeningsinstrument 
ASSIST en bijhorende kortdurende interventie voor alcohol- en 
drugproblemen in de eertslijns welzijns- en gezondheidzorg 
39,650 € 
VAD Kwaliteitsbevordering in de verslavingszorg 73,135 € 
VAD 
 
Ontwikkeling van Good Clinical Practice in de herkenning en 
behandeling van ADHD bij (jong)volwassenen met verslavings 
problemen 
36,975 € 
Total  1,415,450.50 
Source: Federal department of Health, Food chain safety and Environment 
In 2011, the Federal Addiction Fund financed 35 projects focussing on the treatment of (illicit) 
drug addictions. For this period the budget amounted to a total of € 2.932.391. In comparison 
with 2009 we see both an increase in the number of projects and an increase of the budget 
(52%). 
Table 1 4: Funded projects by Federal Addiction Fund 2011  
Institution Title of the Project Budget 
CAD Limburg alcoholhulp.be + CANNABISHULP 185.000 € 
Centre ALFA Jeunes et consommation 55.300 € 
Centre Autrement  
Approche psychothérapeutique pour des clients en démarche 
d’insertion 
32.450 € 
CGG KEMPEN CRA methodiek en een buurtwerking 30.000 € 
CHU BRUGMANN Evaluation, prise en charge et soutien à la prise en charge 
des adolescents souffrant d'une assuétude: approche 
170.000 € 
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 familiale multi dimensionnelle 
Comptoir 
Consultations médicales gratuites et dispensaire de soins 
infirmiers pour usagers de drogues 
72.100 € 
D.U.N.E. 
 
Renfort de l'offre de soins du comptoir d'échange de 
seringues et travail de rue de Bruxelles-Capitale 
72.000 € 
DE KIEM 
 
Ambulante hulp aan drugverslaafden binnen de regelgeving 
van Alternatieve Gerechtelijke Maatregelen, proefzorg en 
drugsbehandelingskamer 
59.516 € 
De Kiem  
Implementatie van een cocainespecifiek 
behandelingsprogramma CRA + vouchers  
89.465,86 € 
DE SLEUTEL 
 
Versterken van kwantiteit en kwaliteit in de preventie, 
vroegdetectie en hulpverlening 
89.000 € 
Ellipse  
CASA : Projet d' accompa-gnement à domicile de per-sonnes 
souffrant ou ayant souffert  d’assuétude(s) 135.470 € 
Het Verhuis-
Siddartha (MSOC 
Vlaams Brabant 
Opvoedingsondersteuning aan druggebruikende ouders en 
hun kinderen in Vlaams-Brabant en 
deskundigheidsbevordering van de laagdrempelige 
hulpverlening aan druggebruikende ouders en hun kinderen 
in Vlaanderen  
57.780 € 
IDA 
 
IDA-web: uitbreding van vlaams en ontwerp van franstalig 
interactive platform voor professionelen en intermediairen 
47.000 € 
IDA 
Projet national d’information et sensibilisation : -16 pas 
d’alcool 
78.825 € 
IDA 
Intervention spécifique sur les problèmes d’alcool dans les 
services des urgences 
79.410 € 
Interstices Bruxelles 
Bruxelles-cannabis … Vers la formation d’un réseau 
spécialisé 
34.800 € 
Interstices CHU St 
Pierre 
Projet Liaison Alcools 70.000 € 
KOMPAS Crisishulp aan huis  57.720 € 
LA CAHO asbl  
 
Implémentation d'un projet de sevrage à domicile de 
personnes alcoolo-dépendantes 
95.500 € 
MASS Bxl- Fédasil 
Projet de collaboration FEDASIL et LAMA - M.A.S.S. - 
Interstices C.H.U. Saint-Pierre 
90.051,98 € 
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MSOC Gent  
Opvang van opiaatafhankelijken in de 
eerstelijnsgezondheidszorg 87.050 € 
MSOC Gent  
 
Klinisch Casemanagement en intervisie  
voor hulpverleners voor drugverslaafde zwangeren 
 en drugverslaafde ouders met jonge kinderen 
69.150 € 
 
MSOC OOSTENDE 
 
Outreachende, geïntegreerde en pro-actieve begeleiding van 
drugafhankelijke ouders met jonge kinderen via A(ssertive) 
C(ommunity) T(reatment) 
79.950 € 
NAMUR ENTRAIDE 
SIDA 
Développement d'un pôle infirmier et médical dans le 
comptoir l'Echange 
75.450 € 
Petits-Riens Synersanté 90.000 € 
PopovGGZ 
 
Optimalisatie van de zorg voor mensen met een 
verstandelijke beperking en een verslavingsprobleem 75.200 € 
Psychiatrisch 
Centrum OLV 
Psychiatrische thuisbegeleiding voor jongeren (16-35j) met 
een psychotische stoornis in combinatie met 
middelenmisbruik (alcohol, drugs) 
51.350 € 
PZ Sint Camillus  
Projectvoorstel intensieve outreach voor het opvolgen van 
personen met een alcoholafhankelijkheid 127.954 € 
Relais Social Urbain 
Namurois  
Cellule assuétudes intégrée au relais santé  77.718,15 € 
Réseau Hépatite C  
Accompagnateur social 
au profit de l’asbl Réseau Hépatite C – Bruxelles 
39.636 € 
ULB & Collaborateur 
(5 partenaires)  
Benzodiazépines : Formations de médecins généralistes et 
d’autres intervenants de santé 
158.669 € 
VAD 
Screening van riskant of problematisch middelengebruik via 
online 'zelftest'-vragenlijsten 55.930 € 
VAD 
 
Ontwikkeling en implementatie van screeningsinstrument 
ASSIST en bijhorende kortdurende interventie voor alcohol- 
en drugproblemen in de eertslijns welzijns- en 
gezondheidzorg 
63.230 € 
VAD Kwaliteitsbevordering in de verslavingszorg 75.715 € 
VAD  
Vroeginterventie door middel van groepswerking met 
jongeren  die riskant of beginnend problematisch gebruiken 204.000 € 
Total   2.932.391 € 
Source: Federal department of Health, Food chain safety and Environment 
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